70 million individuals worldwide experience epileptic seizures, with 80% residing in low-income regions that may cause access to specialized healthcare to be difficult. Microelectrode Arrays (MEAs) have emerged as a new and promising technology that can be used to evaluate electrophysiologically active cells in vitro. With the potential of MEA technology, the purpose of our device is to reach low-income areas and aid in diagnosis before the patient experiences symptoms of epilepsy.
Purpose
Our Product
Our team developed a low-cost microelectrode array system capable of recording neuronal voltage signals to aid specialists in diagnosing patients with epilepsy in low-income regions. This device ensures affordability and portability by optimizing the most cost efficient materials without compromising the effectiveness of our device.

MEA System Market
-
Market Strategy
Discover our targeted market strategy, exploring our defined user base, the expanding market potential, and competitive pricing.
-
Competitors
Uncover the unique advantages the AJAYA MEA System holds in our competitor analysis chart, detailing why we stand above the rest.
Meet the Team
-
Yash Khadilkar
Team Lead
-
Albert Garcia
Co-Hardware Lead
-
Abeline Hernandez
Co-Hardware Lead
-
Jeremiah Andrade
Circuitry Lead
-
Ashley Varatip
Testing and Verification Lead